New hope for advanced stomach cancer: pfizer tests promising drug combo
NCT ID NCT07392892
Summary
This study is testing whether a new drug called PF-08634404 works better when combined with standard chemotherapy for people with advanced stomach, esophageal, or gastroesophageal cancers. The trial has two parts: first checking safety and early effectiveness, then directly comparing the new combination against an existing approved treatment. Researchers aim to see if this approach helps patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.